PLRX - Pliant Therapeutics Inc
1.39
0.070 5.036%
Share volume: 654,678
Last Updated: 03-10-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.17%
PREVIOUS CLOSE
CHG
CHG%
$1.32
0.07
0.05%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q3 2025 | |
| Report Date | 05-06-2024 | 08-07-2024 | 11-07-2024 | 03-03-2025 | 05-08-2025 | 11-06-2025 | |
| Total revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| nan% | nan% | nan% | nan% | ||||
| Operating expenses | 52.392 M | 60.639 M | 62.014 M | 53.320 M | 58.935 M | 28.269 M | |
| Selling general and admin | 15.246 M | 15.022 M | 14.260 M | 14.527 M | 15.499 M | 10.331 M | |
| Research and development | 37.146 M | 45.617 M | 47.754 M | 38.793 M | 43.436 M | 17.938 M | |
| Total expenses | 52.392 M | 60.639 M | 62.014 M | 53.320 M | 58.935 M | 28.269 M | |
| 15.74% | 2.27% | -14.02% | 10.53% | -52.03% | |||
| Operating income | -52.392 M | -60.639 M | -62.014 M | -53.320 M | -58.935 M | -28.269 M | |
| Ebit | -52.392 M | -60.639 M | -62.014 M | -53.320 M | -58.935 M | -28.269 M | |
| Pretax income | -46.955 M | -55.854 M | -57.763 M | -49.732 M | -56.166 M | -26.301 M | |
| 18.95% | 3.42% | -13.90% | 12.94% | -53.17% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | -46.955 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| 100.00% | |||||||
| Net income | -46.955 M | -55.854 M | -57.763 M | -49.732 M | -56.166 M | -26.301 M | |
| -18.95% | -3.42% | 13.90% | -12.94% | 53.17% |